Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119270) titled 'Development of Multi-omics Assisted Early Diagnostic Technology for Cervical Cancer' on Feb. 25.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: China Welfare association international peace Maternal and Child Health hospital
Condition:
Cervical cancer
Intervention:
Gold Standard:Histopathological results from colposcopy and subsequent excisional therapy serve as the gold standard for the diagnosis of cervical cancer and precancerous lesions
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-07
Target Sample Size: Target condition...